Supplemental material
Leukemia & Lymphoma
Volume 59, 2018 - Issue 7
Open access
6,094
Views
20
CrossRef citations to date
0
Altmetric
Review
First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI
Giuseppe SaglioClinical and Biological Sciences of the University of Turin, San Luigi Hospital, Orbassano-Torino, Italy; Correspondence[email protected]
& Elias JabbourDepartment of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Pages 1523-1538
|
Received 03 May 2017, Accepted 05 Sep 2017, Published online: 03 Oct 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.